Skip to main content

Human IFN-Alpha 17 (Alpha I) Protein

Hero Region

Human IFN-Alpha 17 (Alpha I) Protein

Catalog Number: 11150

Human Interferon Alpha 17 recombinant protein expressed in E.coli


Pack Size
Product Info

Recombinant Human Interferon Alpha I (alpha 17) obtained from human leukocyte mRNA expressed in E.coli.


IFN alpha 17 is one of the many interferon alpha subtypes belonging to the Type I leukocyte IFN family.  The Type I IFN family has antiviral, anti-proliferative, and natural killer cell activities.



  • Expression induced by viral infection
  • Encoding gene IFNA17


Formulation Supplied frozen in phosphate-buffered saline (PBS) containing 0.1% Bovine Serum Albumin (BSA)
Molecular Weight 19.3 kDa
Source cDNA obtained from human leukocyte mRNA expressed in E.coli
Purity > 95% by SDS-PAGE stained by Coomassie Blue
Bioactivity Measured using a cytopathic inhibition assay on Bovine Kidney Cells (MDBK) with Vesicular Stomatis Virus (VSV); human lung carcinoma cell line A549 with encephalomyocarditis virus (EMCV)

For retention of full activity store at -70 ºC or below and avoid repeated freeze-thaw cycles

Synonyms Hu-IFN-α17
Accession Number V00532

Tech Info & Data

Application Note


  • A Comparison of the Binding of IFN-Alpha Subtypes to Isolated IFNAR1 and IFNAR2 with Activity in Antiviral and Antiproliferative Assays (link)


6 Citations


  1. Li, Y.,et al., (2023), "An Extracellular Humanized IFNAR Immunocompetent Mouse Model for Analyses of Human Interferon Alpha and Subtypes", Emerg Microbes Infect. 2287681. PMID: 37994664, DOI: 10.1080/22221751.2023.2287681 (link)

  2. Smith, N. et al., (2022), Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity., Nat. Commun. PMID: 36434007, DOI: 10.1038/s41467-022-34895-1 (link)

  3. Smith, et al. (2019). Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement-A new target for lupus treatment. Science Advances, 14 pgs. PMID: 31309143. (link)

  4. Reynolds, et al. (2019). Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles. Arthritis Research & Therapy, 12 pgs. PMID: 31200750. (link)

  5. Wilson, Timothy R, et al. (2012). Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature, 12 pgs. PMID: 22763448. (link)

  6. Kang, Dong-Chul, et al. (2004). Expression Analysis and Genomic Characterization of Human Melanoma Differentiation Associated Gene-5, mda-5: a Novel Type I Interferon-Responsive Apoptosis-Inducing Gene. Oncogene, 12 pgs. PMID: 14676839. (link)


Certificate of Analysis (CoA) and Safety Data Sheet (SDS)
11150-1 CoA

11150-1 Certificate of Analysis (CoA)

11150 SDS

11150 Safety Data Sheet